carbenoxolone sodium has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Huang, G; Ni, Z; Shao, X; Wang, L; Wu, B; Zhou, W | 1 |
| Li, J; Li, W; Sama, AE; Wang, H | 1 |
2 other study(ies) available for carbenoxolone sodium and Sepsis
| Article | Year |
|---|---|
Inhibiting pannexin-1 alleviates sepsis-induced acute kidney injury via decreasing NLRP3 inflammasome activation and cell apoptosis.
Topics: Acute Kidney Injury; Animals; Apoptosis; Autophagy-Related Proteins; Biomarkers; Carbenoxolone; Connexins; Cytokines; Humans; Inflammasomes; Inflammation; Kidney; Kidney Function Tests; Lipopolysaccharides; Male; Mice; Nerve Tissue Proteins; NLR Family, Pyrin Domain-Containing 3 Protein; RNA, Small Interfering; Sepsis | 2020 |
Carbenoxolone blocks endotoxin-induced protein kinase R (PKR) activation and high mobility group box 1 (HMGB1) release.
Topics: Animals; Carbenoxolone; Cell Line; Cells, Cultured; eIF-2 Kinase; HMGB1 Protein; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Receptors, Purinergic P2X7; Sepsis | 2013 |